9TMV | pdb_00009tmv

Akt1 mutant in complex with the 3-ethyl 1-methyl 1,4-substituted pyrazole containing compound and EG


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.90 Å
  • R-Value Free: 
    0.210 (Depositor), 0.211 (DCC) 
  • R-Value Work: 
    0.173 (Depositor), 0.173 (DCC) 
  • R-Value Observed: 
    0.175 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 9TMV

This is version 1.0 of the entry. See complete history

Literature

Isoform-Selective Targeting of Akt Through Covalent Allosteric Inhibition.

D'Angelo, G.D.Pervanidis, K.A.Athanasiadis, I.Lukianchikov, V.Scrima, A.Depta, L.Stier, S.Muller, M.P.Farin, H.F.Quambusch, L.Rauh, D.

(2026) Angew Chem Int Ed Engl : e3567206-e3567206

  • DOI: https://doi.org/10.1002/anie.3567206
  • Primary Citation Related Structures: 
    9TMT, 9TMU, 9TMV, 9TMW, 9TMY, 9TMZ, 9TN0, 9TN1, 9TN2, 9TN3, 9TN4

  • PubMed Abstract: 

    The Akt family of serine/threonine kinases plays a crucial role in various cellular processes, including proliferation, survival, and metabolism. Three Akt isoforms (Akt1, Akt2, and Akt3) have distinct physiological roles, and while individual isoform dysregulation is disease-linked, unselective Akt inhibition leads to side effects. Here, we report the development of selective covalent-allosteric Akt inhibitors (CAAIs) targeting Akt2 and Akt3 while sparing Akt1. Guided by protein x-ray crystallography and molecular modeling, key structural differences within the allosteric pockets of the isoforms were identified and exploited in a structure-based design strategy. By stabilizing the inactive kinase conformation, CAAIs overcome the intrinsic selectivity limitations of ATP-competitive inhibitors. After biological characterization, the pyrazole-containing inhibitors emerged as the most potent and selective Akt2 inhibitors, while inhibitors with pyridines as an isoform-selective element were predominantly targeting Akt3 selectively. Importantly, these new inhibitors were also evaluated in patient-derived colorectal cancer organoids. Co-crystal structures of inhibitors bound to an engineered construct mimicking the Akt2 allosteric pocket elucidated the molecular basis of isoform selectivity, guiding further optimization. This work not only establishes a framework for the development of isoform-selective therapeutics but also highlights the potential for unraveling isoform-specific functions in signaling pathways relevant to cancer biology.


  • Organizational Affiliation
    • Department of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany.

Macromolecule Content 

  • Total Structure Weight: 52.39 kDa 
  • Atom Count: 3,306 
  • Modeled Residue Count: 376 
  • Deposited Residue Count: 445 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
RAC-alpha serine/threonine-protein kinase445Homo sapiensMutation(s): 7 
Gene Names: AKT1PKBRAC
EC: 2.7.11.1
UniProt & NIH Common Fund Data Resources
Find proteins for P31749 (Homo sapiens)
Explore P31749 
Go to UniProtKB:  P31749
PHAROS:  P31749
GTEx:  ENSG00000142208 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP31749
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 2 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
A1JWX(
Subject of Investigation/LOI)

Query on A1JWX



Download:Ideal Coordinates CCD File
C [auth A]~{N}-[3-[1-[[4-[5-[(3-ethyl-1-methyl-pyrazol-4-yl)methyl]-3-phenyl-pyridin-2-yl]phenyl]methyl]piperidin-4-yl]-2-oxidanylidene-1~{H}-benzimidazol-5-yl]propanamide
C40 H43 N7 O2
KSUOJTMEWGPAKM-UHFFFAOYSA-N
EDO

Query on EDO



Download:Ideal Coordinates CCD File
B [auth A]1,2-ETHANEDIOL
C2 H6 O2
LYCAIKOWRPUZTN-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.90 Å
  • R-Value Free:  0.210 (Depositor), 0.211 (DCC) 
  • R-Value Work:  0.173 (Depositor), 0.173 (DCC) 
  • R-Value Observed: 0.175 (Depositor) 
Space Group: P 1 21 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 49.61α = 90
b = 71.17β = 107.27
c = 67.74γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
XDSdata reduction
XSCALEdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Other governmentNW21-062C
Other privateTACTIC
European Regional Development FundEuropean UnionEFRE-800400
German Research Foundation (DFG)Germany--

Revision History  (Full details and data files)

  • Version 1.0: 2026-09-16
    Type: Initial release